摘要
目的研究结核感染T细胞斑点实验(T—SPOT.TB)对结核性胸膜炎患者的诊断价值。方法比较T—SPOT.TB、ADA检测110例渗出性胸腔积液患者的阳性率、灵敏度、特异度、阳性预测值、阴性预测值等;比较治疗前后T—SPOT.TB斑点数的变化。结果T—SPOT.TB检测结核性胸膜炎患者的灵敏度、特异度、阳性预测值、阴性预测值、约登指数分别为89.66%、86.54%、88.14%、88.24%、0.76。ADA检测的灵敏度、特异度、阳性预测值、阴性预测值、约登指数分别为74.14%、75.00%、76.79%、72.22%、0.49。T—SPOT.TB的灵敏度、特异度明显高于ADA,差异有统计学意义(均P〈0.05)。抗结核治疗后的结核性胸膜炎患者经ESAT-6和CFP-10刺激产生的斑点数明显低于抗结核治疗前(均P〈0.05)。结论T—SPOT.TB对结核性胸膜炎有较好的辅助诊断价值,在抗结核治疗效果监测方面有一定的指导意义。
Objective To explore the value of T-SPOT.TB test in the diagnosis of tuberculous pleurisy. Methods The positive rate, sensitivity, specificity, positive predictive value, and negative predictive value of T-SPOT.TB and ADA were calculated and compared. Among these patients, 40 were retested by T-SPOT.TB after anti-tuberculosis treatment; and spot forming cells (SFCs) were compared before and after the treatment. Results The sensitivity, specificity, positive predictive value, and negative predictive value of T-SPOT.TB were 89.66%, 86.54%, 88.14%, 88.24%, and 0.76. And those of ADA were 74.14%, 75.00%, 76.79%, 72.22%, and 0.49. The sensitivity and specificity of T-SPOT.TB were significantly higher than those of ADA, with statistical differences (P〈0.05). 40 patients were retested by the T-SPOT.TB after anti-TB treatment, and the results showed that ESAT- 6 and CFP-10 specific SFCs decreased significantly compared with those before anti-TB treatment (P〈0.05). Conclusion T-SPOT.TB assay has an important clinical value in the diagnosis of tuberculous pleurisy and help us monitor treatment response.
出处
《国际医药卫生导报》
2018年第4期520-523,共4页
International Medicine and Health Guidance News